Tor Biering-Sørensen, MD, MSc, MPH, PhD
@TorBiering
Professor and Head of Center for Translational Cardiology and Pragmatic Randomized Trials (@CTCPR_). Cardiac imaging, heart failure and RCT’s.
ID:1269594190708715522
https://www.gentoftehospital.dk/ctcpr 07-06-2020 11:37:13
933 Tweets
1,1K Followers
678 Following
Had tons of fun with Prof. Køber today attempting to convince the audience that guidelines are not useful and important in a pro/con session against Kieran Docherty and Prof. McMurray at the Danish Cardiovascular Academy #HeartFailure summit - who won the debate?
An intriguing study reveals how the E/SRe ratio predicts atrial fibrillation post-ST-elevation myocardial infarction. This innovative non-invasive measurement showcases promising potential in predicting cardiac outcomes. @carlolineloekke #Cardiology
pubmed.ncbi.nlm.nih.gov/37957448/
🔍 New study! Fascinating findings reveal how hypertension influences the association between myocardial work indices and cardiovascular events in the general population. 🫁💔Flemming Javier Olsen Discover more about this groundbreaking research here: pubmed.ncbi.nlm.nih.gov/37930752/
Tor Biering-Sørensen, MD, MSc, MPH, PhD CPR Trials & CIRL Herlev og Gentofte hosp afd for hjertesygdomme Niklas Dyrby Johansen Muthu Vaduganathan Department of Biomedical Sciences | UCPH University of Copenhagen Research HerlevGentofte Hosp. Brigham and Women’s Research Thanks for the opportunity Tor Biering-Sørensen, MD, MSc, MPH, PhD CPR Trials & CIRL . Massive potential for #impsci here given recent 1A guideline recommendations & data suggesting a large proportion of the population (>20%) remains vaccine-unsure in the US, with little to no narrowing of this gap over time.
European Society of Cardiology guidelines provide 🌟Class IA recc for flu vacc 💉 in pts w/ AMI to ⏬ MACE. Yet, few #impsci programs focus on this group. In European Society of Cardiology Journals, we found behavioral messaging highlighting ❤️ benefits of 💉resulted in a 2.6% ⏫ in vaccine rates in pts w/ AMI. Tor Biering-Sørensen, MD, MSc, MPH, PhD
Dr. Ankeet S. Bhatt, MD, MBA elegantly explains our most recent findings from the NUDGE-FLU trail in citizens with a previous MI. Great job my friend!
academic.oup.com/eurheartj/adva…
CPR Trials & CIRL Herlev og Gentofte hosp afd for hjertesygdomme Niklas Dyrby Johansen Muthu Vaduganathan Department of Biomedical Sciences | UCPH University of Copenhagen Research HerlevGentofte Hosp. Brigham and Women’s Research
Our most recent publication from the NUDGE-FLU trial lead by my brilliant friend and colleague Dr. Ankeet S. Bhatt, MD, MBA, assessing the effectiveness of electronic nudge letters to increase flu vaccine uptake amongst citizens with a previous MI
Department of Biomedical Sciences | UCPH CPR Trials & CIRL University of Copenhagen Research Harvard University
Exciting news from our talented researchers and collaborators presenting their findings at #ACC24 in Atlanta! 🎉3 out of 4 abstracts were simultaneously published with their presentations💪
link.springer.com/article/10.100…
academic.oup.com/eurheartj/adva…
…ubs.pericles-prod.literatumonline.com/doi/10.1111/do…
Excellent tweetorial from Tony Breu on hemoglobin change after sglt2i initiation!
We were recently able to show this exact phenomenon in patients with T2DM using nationwide data pubmed.ncbi.nlm.nih.gov/38594550/
Tor Biering-Sørensen, MD, MSc, MPH, PhD Michael Fralick Manan Pareek, MD, PhD, FAHA, FESC
📢 New research uncovers the predictive power of right ventricular strain in identifying heart failure risk in the general population. 🫀💔Learn more about the study's insights into RV free wall and four-chamber longitudinal strain here: #Cardiology
pubmed.ncbi.nlm.nih.gov/37878747/
Association between SGLT2i initiation and change in hemoglobin 🩸 in adults with DM - a nationwide study 🇩🇰
SGLT2i use vs. DPP4i use was associated with a +0.43g/dL increase ⬆️ in hemoglobin 🩸
Now published in JGIM Journal of General Internal Medicine 📖
Tor Biering-Sørensen, MD, MSc, MPH, PhD Michael Fralick CPR Trials & CIRL
Proud to be Danish today and great day to be in Atlanta to witness Professor Møller present the results of the DanGer shock trial!
Despite being a small country we continue to deliver ground breaking science to the World.
Congratulations to the whole DanGer shock team.
CPR Trials & CIRL
Join us tomorrow at #ACC24 for 2 studies:
The effect of high-dose vs standard-dose flu vacc 💉 on clinical outcomes in the DANFLU-1 trial by DM status 🏥
Assoc. between SGLT2i initiation 💊and hemoglobin 🩸change in T2DM - a nationwide study
Tor Biering-Sørensen, MD, MSc, MPH, PhD Michael Fralick CPR Trials & CIRL
What a tremendous pleasure to visit Duke Clinical Research Institute & Duke Cardiology for the first time. Thanks to Marat Fudim, MD MHS Steve Greene Robert Mentz, MD and Adrian “WE NEED RCTS!” Hernandez for hosting me! Looking very much forward to collaborating with you all to make sure these pragmatic RCT’s also come to NC and USA 🇺🇸
Tor Biering-Sørensen, MD, MSc, MPH, PhD is a star in every way. What he and the team at CPR Trials & CIRL have done to date has set the standard for large, fast, pragmatic, simple trials. Proud to call him a friend and colleague.Muthu Vaduganathan.
What a privilege to welcome Tor Biering-Sørensen, MD, MSc, MPH, PhD to Duke Clinical Research Institute and have round table discussion with fellows to talk pragmatic trial design and more!
Nina Satoshi Shoji, MD, PhD Joe Lerman, MD Marat Fudim, MD MHS Robert Mentz, MD Adrian “WE NEED RCTS!” Hernandez Duke Cardiology Fellows